Changes to the QTdrugs List and List of Drugs to Avoid in CLQTS

Dear CredibleMeds Registrants:

AZCERT's Scientific Review Committee has found substantial evidence that Bilastine (antihistamine) and Gepotidacin (antibiotic)  are associated with the development of QT prolongation but lack convincing evidence of causing torsades de pointes (TdP).  Therefore, these drugs have been added to the Possible Risk of TdP category (PR) and to the List of Drugs to Avoid in patients with Congenital Long QT Syndrome (DTA List).

To perform a quick search of the most current versions of the QTdrugs List we recommend using the CredibleMeds website or one of the available smartphone apps (Apple or Android).  Please note that new versions of the smartphone apps are now available:  BASIC (free), STANDARD AND PRO (Augmented features and available by subscription). 

As demonstrated by these revisions, the QTdrugs List and the DTA are dynamic and change regularly in response to changes in the scientific evidence that is available. Your support makes our neutral, evidence-based process possible.

We do need your help to maintain the QTdrugs List, the DTA List and the CredibleMeds website.  Please consider making a contribution to support AZCERT's work.  Click here or the button below to donate now.

Sincerely,

Ray Woosley, MD, PhD and the Scientific Review Committee for AZCERT
Will Heise, MD, Tyler Gallo, PharmD, R. David Woosley, MPH, Joseph Lambson, PharmD